Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs Recall
Issued April 10, 2025 · Kramer Laboratories · 14,250 units affected
In April 2025, Kramer Laboratories recalled the Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs, a low-risk health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
What you should do
- 1 Stop using Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Kramer Laboratories to arrange your refund. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Recall details
- Brand
- Kramer Laboratories
- Category
- Health
- Recall date
- April 10, 2025
- Units affected
- 14,250
- Sold at
- HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.
- Recall number
- CPSC-25223
- Made in
- India
- Issuing agency
- CPSC
In context
- Kramer Laboratories has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- 14,250 units is enough to reach roughly 1 in every 9,193 US households.
- This is the 691st Health recall we've logged in 2025.